跨年行情的概率较高，聚焦同类规模最大的自由现金流ETF（159201）配置价值

Core Viewpoint - The market is experiencing a potential upward breakout in December, driven by positive economic policy expectations and strong inflows into cash flow ETFs, indicating a favorable investment environment [1]. Group 1: Market Performance - On December 2, the Guozheng Free Cash Flow Index opened lower but showed an upward trend, with a narrowed decline of approximately 0.15% [1]. - Leading stocks include Yaxiang Integration, Huaren Health, and Yifeng Pharmacy, which are driving the index performance [1]. Group 2: ETF Inflows - The largest free cash flow ETF (159210) has seen continuous net inflows over the past 17 days, totaling 1.981 billion yuan, reaching a new high of 7.466 billion yuan in total assets [1]. - The free cash flow ETF (159201) and its linked funds (A: 023917; C: 023918) closely track the Guozheng Free Cash Flow Index, focusing on stocks with positive and high cash flow [1]. Group 3: Investment Strategy - The index is characterized by high quality and strong risk resistance, making it suitable for long-term investment and core portfolio allocation [1]. - The annual management fee for the funds is 0.15%, and the custody fee is 0.05%, both of which are the lowest in the market, maximizing benefits for investors [1]. Group 4: Economic Outlook - According to招商证券, after three months of market consolidation, the probability of a December breakout leading to a year-end rally is high [1]. - The upcoming 2026 is seen as a critical year ahead of the 20th National Congress, with expectations for more proactive economic policies from the December Politburo meeting and Central Economic Work Conference, which could enhance confidence in economic recovery and corporate profitability [1].